ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
作者信息
AUERSWALD W, BERNHEIMER H, DOLESCHEL W
出版信息
Med Pharmacol Exp Int J Exp Med. 1965;12:81-91. doi: 10.1159/000135531.
PMID:14279888
Abstract
摘要
相似文献
1
ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
Med Pharmacol Exp Int J Exp Med. 1965;12:81-91. doi: 10.1159/000135531.
2
ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE.
Med Exp Int J Exp Med. 1964;10:179-84. doi: 10.1159/000135414.
3
[THE SOLUBILITY OF FIBRIN DEPOSITS].
Verh Dtsch Ges Pathol. 1963;47:232-4.
4
FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
Thromb Diath Haemorrh. 1965 Jun 15;13:484-91.
5
THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
Obstet Gynecol. 1964 Jan;23:12-6.
6
INCREASE IN FIBRINOLYTIC ACTIVITY BY VENOUS OCCLUSION.
J Appl Physiol. 1963 Nov;18:1123-9. doi: 10.1152/jappl.1963.18.6.1123.
7
FIBRINOGEN BREAKDOWN PRODUCTS.
Am J Physiol. 1964 Nov;207:1053-7. doi: 10.1152/ajplegacy.1964.207.5.1053.
8
EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
Am J Physiol. 1964 Nov;207:1044-8. doi: 10.1152/ajplegacy.1964.207.5.1044.
9
FIBRINOLYSIS.
Conn Med. 1964 Sep;28:662-7.
10
STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
Clin Sci. 1965 Jun;28:527-36.
Zotero 插件